FedEx to Exhibit Industry-Leading Healthcare Solutions at BioLogistics World Asia 2024
Singapore, March 11, 2024 — FedEx Express (FedEx), a subsidiary of FedEx Corp. (NYSE: FDX) and one of the world’s largest express transportation companies, will showcase its tailored transportation solutions for the healthcare sector at the BioLogistics World Asia 2024 in Singapore from 19th -21st March.
The healthcare industry, including clinical research, pharmaceuticals and biotech, diagnostics and medical equipment and supplies, has many unique and highly regulated logistics needs tied to the sensitivity of shipments. Requirements range from ensuring temperature integrity, speed of delivery, white glove support and contingency planning.
For decades, FedEx has been using its cold chain network and dedicated healthcare team to ship vaccines, biologics, and medical aid all around the world. FedEx uses its four Life Science Centers in the region including South Korea, Japan, Singapore and Mumbai and its fleet of more than 680 aircraft and 200,000 vehicles to move healthcare shipments using temperature-controlled solutions from -150oC to +25oC and real-time monitoring capabilities.
FedEx customized solutions for the industry comply with trade and regulatory requirements including FedEx® Clinical Care, an end-to-end solution for time and temperature sensitive bio-samples, kits, and investigation medicinal products. FedEx package tracking technology includes FedEx SenseAware which monitors multiple parameters in real time to ensure shipment integrity.
BioLogistics World Asia organized by IMAPAC, is a premier conference for biologics and logistics in the Asia Pacific region to demonstrate best practices in cold chain management. FedEx Healthcare team members will also be participating in the plenary sessions and will deliver a keynote speech on the region’s rapidly evolving healthcare needs.
